Published in World J Gastrointest Pathophysiol on August 15, 2014
Endothelial dysfunction in inflammatory bowel diseases: Pathogenesis, assessment and implications. World J Gastroenterol (2016) 0.80
Obesity Downregulates MicroRNA-126 Inducing Capillary Rarefaction in Skeletal Muscle: Effects of Aerobic Exercise Training. Oxid Med Cell Longev (2017) 0.75
Associations of Bowel Movement Frequency with Risk of Cardiovascular Disease and Mortality among US Women. Sci Rep (2016) 0.75
Vedolizumab: toward a personalized therapy paradigm for people with ulcerative colitis. Clin Exp Gastroenterol (2017) 0.75
Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med (2005) 28.21
Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet (2010) 5.63
Limitations of the application of fourfold table analysis to hospital data. Biometrics (1946) 5.44
Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore) (2003) 4.00
Cardiovascular effects of tumour necrosis factor α antagonism in patients with acute myocardial infarction: a first in human study. Heart (2013) 3.94
Vascular complications of inflammatory bowel disease. Mayo Clin Proc (1986) 3.00
Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats. Circulation (1998) 2.77
Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis. Ann Rheum Dis (2010) 2.39
Risk of cerebrovascular accidents and ischemic heart disease in patients with inflammatory bowel disease: a systematic review and meta-analysis. Clin Gastroenterol Hepatol (2013) 2.38
Risk of ischaemic heart disease in patients with inflammatory bowel disease: a nationwide Danish cohort study. Gut (2012) 2.34
The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study. Thromb Haemost (2001) 2.31
Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis (2012) 2.24
Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients. Am J Gastroenterol (2008) 2.09
Coagulation studies in ulcerative colitis and Crohn's disease. Gastroenterology (1975) 2.08
The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population-based study. Clin Gastroenterol Hepatol (2007) 1.91
Inflammatory bowel disease is associated with an increased incidence of cardiovascular events. Am J Gastroenterol (2011) 1.88
Disease activity in inflammatory bowel disease is associated with increased risk of myocardial infarction, stroke and cardiovascular death--a Danish nationwide cohort study. PLoS One (2013) 1.78
Thromboembolic events and cardiovascular mortality in inflammatory bowel diseases: a meta-analysis of observational studies. J Crohns Colitis (2013) 1.71
Venous thromboembolism in inflammatory bowel disease. Am J Gastroenterol (2004) 1.69
Survival and causes of death in patients with inflammatory bowel disease: a population-based study. Gastroenterology (1992) 1.65
Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis. Eur Heart J (2013) 1.53
Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure. Br Heart J (1991) 1.50
Identification of a novel role for sphingolipid signaling in TNF alpha and ischemic preconditioning mediated cardioprotection. J Mol Cell Cardiol (2002) 1.49
Risk of arterial thrombotic events in inflammatory bowel disease. Am J Gastroenterol (2009) 1.47
Prothrombotic state and signs of endothelial lesion in plasma of patients with inflammatory bowel disease. Dig Dis Sci (1995) 1.29
Venous thromboembolism in inflammatory bowel disease: an epidemiological review. Am J Gastroenterol (2011) 1.27
Enhanced atherogenesis and altered high density lipoprotein in patients with Crohn's disease. J Lipid Res (2007) 1.17
Statins are associated with reduced use of steroids in inflammatory bowel disease: a retrospective cohort study. Inflamm Bowel Dis (2011) 1.17
Risk of ischemic stroke in patients with Crohn's disease: a population-based nested case-control study. Inflamm Bowel Dis (2010) 1.14
Review article: mode of action and delivery of 5-aminosalicylic acid - new evidence. Aliment Pharmacol Ther (2006) 1.14
Cerebrovascular occlusions in relatively young patients with regional enteritis. JAMA (1971) 1.12
Is inflammatory bowel disease a risk factor for early atherosclerosis? Angiology (2009) 1.06
Effects of the tumor necrosis factor-α antagonist adalimumab on arterial inflammation assessed by positron emission tomography in patients with psoriasis: results of a randomized controlled trial. Circ Cardiovasc Imaging (2012) 1.00
Evidence of endothelial dysfunction in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol (2008) 1.00
Ischemic stroke and peripheral arterial thromboembolism in a patient with Crohn's disease: a case presentation. J Neurol Sci (2007) 0.98
The vasculature and inflammatory bowel disease: contribution to pathogenesis and clinical pathology. Inflamm Bowel Dis (2005) 0.96
Crohn's disease and ulcerative colitis are associated with elevated standardized mortality ratios: a meta-analysis. Inflamm Bowel Dis (2013) 0.96
Psoriasis and vascular disease-risk factors and outcomes: a systematic review of the literature. J Gen Intern Med (2011) 0.95
Acquired protein C and S deficiency, inflammatory bowel disease and cerebral arterial thrombosis. Blut (1990) 0.94
Prothrombin fragment 1 + 2 and thrombin-antithrombin III complex as markers of activation of blood coagulation in inflammatory bowel diseases. Eur J Gastroenterol Hepatol (1995) 0.92
Trends in overall and cause-specific mortality among patients with inflammatory bowel disease from 1982 to 2010. Clin Gastroenterol Hepatol (2012) 0.90
Free protein S deficiency in patients with chronic inflammatory bowel disease. Scand J Gastroenterol (1992) 0.90
Is there an association between inflammatory bowel diseases and carotid intima-media thickness? Preliminary data. Angiology (2013) 0.87
Comprehensive study of cardiovascular morbidity in hospitalized inflammatory bowel disease patients. J Crohns Colitis (2011) 0.87
Rates of pharmacologic venous thromboembolism prophylaxis in hospitalized patients with active ulcerative colitis: results from a tertiary care center. J Crohns Colitis (2013) 0.86
Risk factors for intestinal ischaemia among patients registered in a UK primary care database: a nested case-control study. Aliment Pharmacol Ther (2011) 0.85
Biologics and the cardiovascular system: a double-edged sword. Antiinflamm Antiallergy Agents Med Chem (2013) 0.83
Large-artery stroke in a young patient with Crohn's disease. Role of vitamin B6 deficiency-induced hyperhomocysteinemia. J Neurol Sci (2004) 0.82
Arterial thrombosis in Crohn's disease. Med J Aust (1988) 0.82
Free protein S deficiency in patients with Crohn's disease. Scand J Gastroenterol (1994) 0.81
Inflammatory bowel disease and coronary artery disease. Indian J Gastroenterol (2009) 0.77
Risk of infections associated with biological treatment in inflammatory bowel disease. World J Gastroenterol (2014) 0.90
Has the risk of colorectal cancer in inflammatory bowel disease decreased? World J Gastroenterol (2013) 0.88